|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07D 239/91 | |
| C07D 403/04 | |||
| C07D 403/02 | |||
| A61K 31/517 | |||
| A61K 31/519 | |||
| A61P 9/00 |
| (11) | Patento numeris | 2660238 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 13175561.3 |
| Europos patento paraiškos padavimo data | 2010-01-08 | |
| (97) | Europos patento paraiškos paskelbimo data | 2013-11-06 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2015-05-06 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 143276 P | 2009-01-08 | US |
| (72) |
Hansen, C., Henrik, CA
|
| (73) |
Resverlogix Corporation,
300, 4820 Richard Road SW Calgary, AB T3E 6L1,
CA
|
| (54) | Compounds for the prevention and treatment of cardiovascular disease |
| Compounds for the prevention and treatment of cardiovascular disease |